219 related articles for article (PubMed ID: 2476813)
21. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
22. Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.
Worlock AJ; Zalutsky MR; Metzgar RS
Cancer Res; 1990 Nov; 50(22):7246-51. PubMed ID: 2224857
[TBL] [Abstract][Full Text] [Related]
23. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.
Bigner DD; Brown M; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Bigner SH; Zhao XG; Wikstrand CJ; Pegram CN
J Neurooncol; 1995; 24(1):109-22. PubMed ID: 8523067
[TBL] [Abstract][Full Text] [Related]
24. Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.
Vaidyanathan G; Bigner DD; Zalutsky MR
J Nucl Med; 1992 Aug; 33(8):1535-41. PubMed ID: 1634947
[TBL] [Abstract][Full Text] [Related]
25. Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.
McLendon RE; Archer GE; Larsen RH; Akabani G; Bigner DD; Zalutsky MR
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):491-9. PubMed ID: 10487576
[TBL] [Abstract][Full Text] [Related]
26. Radioimaging of experimental glioma grafts using F (ab')2-fragments of monoclonal antibodies.
Stavrou D; Glässner H; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1986; 6(5):897-903. PubMed ID: 3800333
[TBL] [Abstract][Full Text] [Related]
27. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.
Hauck ML; Larsen RH; Welsh PC; Zalutsky MR
Br J Cancer; 1998 Mar; 77(5):753-9. PubMed ID: 9514054
[TBL] [Abstract][Full Text] [Related]
29. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.
Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR
Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844
[TBL] [Abstract][Full Text] [Related]
30. Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude mice.
Bäck T; Haraldsson B; Hultborn R; Jensen H; Johansson ME; Lindegren S; Jacobsson L
Cancer Biother Radiopharm; 2009 Dec; 24(6):649-58. PubMed ID: 20025544
[TBL] [Abstract][Full Text] [Related]
31. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
32. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
34. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
Hadley SW; Wilbur DS; Gray MA; Atcher RW
Bioconjug Chem; 1991; 2(3):171-9. PubMed ID: 1932216
[TBL] [Abstract][Full Text] [Related]
35. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.
Zalutsky MR; Vaidyanathan G
Curr Pharm Des; 2000 Sep; 6(14):1433-55. PubMed ID: 10903402
[TBL] [Abstract][Full Text] [Related]
36. Selective tumor localization of radiolabeled anti-human melanoma monoclonal antibody fragment demonstrated in the nude mouse model.
Buchegger F; Mach JP; Leonnard P; Carrel S
Cancer; 1986 Aug; 58(3):655-62. PubMed ID: 2425921
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution of 211At-labeled humanized monoclonal antibody A33.
Almqvist Y; Steffen AC; Lundqvist H; Jensen H; Tolmachev V; Sundin A
Cancer Biother Radiopharm; 2007 Aug; 22(4):480-7. PubMed ID: 17803442
[TBL] [Abstract][Full Text] [Related]
38. Exploration of a F(ab')
Milenic DE; Kim YS; Baidoo KE; Wong KJ; Barkley R; Delgado J; Brechbiel MW
Cancer Biother Radiopharm; 2018 Jun; 33(5):182-193. PubMed ID: 29916748
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
40. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
